VTU Technology GmbH
Pichia pastoris Protein Expression / Production Excellence
VTU Technology is a leading contract research and development company providing time-saving development of cost-efficient recombinant protein production processes for manufacturing of biologics and other proteins.
VTU delivers high performance production strains and entire processes with record-breaking productivity (recently reaching 35 g/l of secreted protein). As a leading contract research organization, VTU provides exclusive services and technologies around Pichia pastoris protein production and process development in step wise and highly customized project setups.
Cutting-edge, proprietary technologies and profound experience are the basis for the broadest toolbox available for Pichia pastoris recombinant protein production enabling the expression of a wide range of proteins such as Fabs & Antibody-derived fragments, Fc & HSA fusion proteins, scaffold proteins, serum proteins, cytokines, vaccines and enzymes.VTU additionally offers the generation of glycoproteins with human-like glycoforms by combining our yield enhancing Pichia platform with PichiaGlycoswitch®.
Since its foundation 2008, our highly skilled team has been continuously optimizing and expanding its Pichia technology platform to generate an unparalleled spectrum of expression tools and ingenious expression strategies leading to more flexibility in protein production and to meet highly specific expression needs. Multiple customers from different industries have already benefited from VTU´s versatile Pichia platform.
- High speed expression strain development
- Fermentation process development and optimization
- Downstream and analytical process development
- Small-scale production of purified proteins
- Sound technology & data transfer to our customers
- Out-licensing / co-development opportunities for several recombinant proteins.
VTU guarantees tight development timelines and competitive & safe production processes.Contact
To learn more about VTU's services and capabilities and how they can assist your business, please contact VTU Technology directly.
- > Pichia pastoris - Protein Production Excellence
- > VTU Technology to ‘unlock Pichia’ at PepTalk 2018
- > Custom Glycoprotein Production in Pichia pastoris
- > VTU Technology bringing Pichia advances to leading European events
- > VTU Technology brings protein expression to CPhI
- > VTU Technology’s new website unlocks Pichia toolbox
- > VTU Technology presenting Pichia production opportunities at BIO International
- > High level methanol-free phytase production in Pichia pastoris
- > VTU Technology presenting broadest Pichia pastoris protein production toolbox at BIO Europe Spring 2017
- > VTU Technology revealing protein expression advances at PepTalk San Diego
- > VTU Technology bringing Pichia advances to BIO Europe and ESIB
- > VTU Technology taking Pichia advances to CPhI Barcelona 2016
- > VTU Technology bring out licensing opportunities to BIO-International 2016
- > Evercyte and VTU Technology collaborate on development of recombinant media supplements
- > VTU Technology and Boehringer Ingelheim strengthen their global microbial technology collaboration
- > VTU bringing advanced protein expression to key European conferences
- > VTU bringing latest technologies to Pichia 2016, Turkey and 4th BioproScale Symposium, Germany
- > Pichia production of albumin fusion proteins
- > VTU bringing advanced protein expression to BIO-Europe
- > Spotlight on methanol-free protein production
- CRO, CMO, CRAMS & CDMO
- Drug Discovery
- Manufacturing & Production